Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Inventory

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 posts a inventory of $1.4M as of March 2026. That compares with $3.9M in the prior-year period — down 64.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Deep Medicine Acquisition - Tradeable Rights - Oct 2026's inventory was $3.9M. The latest reading is $1.4M — a 64.7% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of Deep Medicine Acquisition - Tradeable Rights - Oct 2026's financial statement story. At $1.4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for DMAQR's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Deep Medicine Acquisition - Tradeable Rights - Oct 2026's other metric pages and overview cover the third.